BioMarin Pharmaceutical Inc. buy Barclays PLC
Start price
06.08.24
/
50%
€79.46
Target price
06.08.25
€100.74
Performance (%)
-34.76%
End price
07.08.25
€51.84
Summary
This prediction ended on 07.08.25 with a price of €51.84. The BUY prediction by Barclays_PLC for BioMarin Pharmaceutical Inc. performed very badly with a performance of -34.76%. Barclays_PLC has a follow-up prediction for BioMarin Pharmaceutical Inc. where he still thinks BioMarin Pharmaceutical Inc. is a Buy. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| BioMarin Pharmaceutical Inc. | -2.559% | -2.559% | 20.756% |
| iShares Core DAX® | -1,06 % | 5,01 % | 6,60 % |
| iShares Nasdaq 100 | -2,39 % | 0,86 % | 25,79 % |
| iShares Nikkei 225® | -4,36 % | 1,21 % | 41,31 % |
| iShares S&P 500 | -1,78 % | 1,39 % | 21,04 % |
Comments by Barclays_PLC for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its price target lowered by analysts at Barclays PLC from $111.00 to $110.00. They now have an "overweight" rating on the stock.
Ratings data for BMRN provided by MarketBeat
In the thread Trading BioMarin Pharmaceutical Inc.
Die von Barclays_PLC gewählte maximale Laufzeit wurde überschritten
Current prediction by Barclays_PLC for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€46.90
28.10.25
28.10.25
€68.62
28.10.26
28.10.26
23.58%
20.08.26
20.08.26
Stopped prediction by Barclays_PLC for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€57.92
17.08.26
17.08.26
€95.86
17.08.27
17.08.27
0.07%
20.08.26
20.08.26
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€47.65
28.01.26
28.01.26
€66.71
28.01.27
28.01.27
21.64%
20.08.26
20.08.26
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€62.80
04.10.24
04.10.24
€78.35
04.10.25
04.10.25
-24.70%
05.10.25
05.10.25